Deloitte July 15, 2024
Jessica Syslo, Ismail Kassam, Christi Hall, Leena Gupta, Natasha Elsner, Apoorva Singh

Biopharma’s early digitization efforts showcase the need to adopt a more comprehensive development strategy for the supply chain workforce and other functions

Many biopharma companies are digitally transforming their supply chains1 to help prepare for future challenges. Over the past year, we have explored how digitizing processes and information can help supply chains become more resilient and sustainable. In this fourth and final installment of our biopharma supply chain series, we turn our attention to the transformation’s impact on the workforce. Workers are not just being affected by this change—they are the agents enabling and implementing it, so they must adapt to using the latest technologies in their roles.

In 2023, the Deloitte Center for Health Solutions...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Pharma, Pharma / Biotech, Supply Chain, Survey / Study, Technology, Trends
Pharma Dodges The Tariff Bullet — But For How Long?
PBM Private Labeling Boosts Biosimilars, Raises Concerns
Biotech ‘megarounds’ hold steady as startups, VCs wait on IPOs
How BioPharma Can Improve Consumers’ Experience and Health
The Go-To Law Firms For Healthcare and Life Sciences

Share This Article